2. Academic Validation
  3. 5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline

5-Iminodaunorubicin. Reduced cardiotoxic properties in an antitumor anthracycline

  • J Med Chem. 1979 Jan;22(1):36-9. doi: 10.1021/jm00187a009.
G L Tong,  D W Henry,  E M Acton
PMID: 423181 DOI: 10.1021/jm00187a009
Abstract

Treatment of daunorubicin with methanolic ammonia affords 5-iminodaunorubicin, the first quinone-modified analogue of either daunorubicin or adriamycin. This product retains antileukemic activity in mice, is less cardiotoxic by electrocardiographic measurements in rats, and is nonmutagenic in Salmonella typhimurium (Ames test).

Figures